TRIM21 and cardiac hypertrophy: Negative regulation of Nrf2-antioxidant axis is a common mechanism in TRIM21-mediated heart diseases, and has been verified in TAC-induced cardiac hypertrophy 22, doxorubicin-induced cardiotoxicity 23, and myocardial infarction-induced atrial remodeling 26.